Swiss National Bank’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
Swiss National Bank's NUVB Position: Q1 2026 in Review
Swiss National Bank held its Nuvation Bio (NUVB) position steady in Q1 2026 at 437,400 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1881.
Swiss National Bank first reported a position in NUVB in Q2 2021 and has held it in 18 quarters since. The position peaked at $3.92M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- Swiss National Bank held 437,400 shares of Nuvation Bio worth $1.88M as of Q1 2026.
- Swiss National Bank left its Nuvation Bio share count unchanged in Q1 2026.
- Nuvation Bio made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1881 holding.
- Swiss National Bank first reported a position in Nuvation Bio in Q2 2021 and has held it in 18 quarters since.
- Swiss National Bank's Nuvation Bio position peaked at $3.92M in Q4 2025.
- 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.